Jazz Pharmaceuticals develops and sells medicines for rare diseases, including sleep disorders, epilepsy and cancer. It last closed at $230.26 on Nov 20, down 2.62% on the day. The next earnings report for JAZZ is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, JAZZ reported EPS of -$7.48 on revenue of $1.24B, with revenue up 10.4% from a year ago. Over its last 8 reports the stock moved an average of 5.6% the session after earnings. Over the last 12 months JAZZ insiders bought $0 of stock on the open market and sold $81.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is JAZZ in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold JAZZ.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on JAZZStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
JAZZ · as of the Nov 20 close · updated each morning
Uptrend
The stock is 0% above its 20 day and 1% above its 50 day average. It is 4% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 49). The nearest support is the 20 day average at $229.82, and the nearest resistance the Pivot at $232.27.
Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 3.5%/day
Key levels
$266.3852 week high+15.7%
$239.02100 day average+3.8%
$238.87Swing high (Oct 5)+3.7%
$236.58Pivot R1+2.7%
$232.27Pivot+0.9%
$230.26Last close
$229.8220 day average−0.2%
$229.16Swing low (Sep 29)−0.5%
$228.7450 day average−0.7%
$225.94Pivot S1−1.9%
$221.86200 day average−3.6%
$156.9552 week low−31.8%
Indicators
RSI (14)
48.75
Middle of its range
Neutral
MACD
4.40
Above its signal line
Bullish
Stochastic
64.8
Middle of its range
Neutral
ADX (14)
27.4
Trending down
Williams %R
-62.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
13.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.9%
Change over 10 sessions
Bearish
ATR (14)
$8.10
Typical daily range, 3.5% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 6.5%/day
Key levels
$266.3852 week high+15.7%
$239.02100 day average+3.8%
$238.87Swing high (Oct 5)+3.7%
$236.58Pivot R1+2.7%
$232.27Pivot+0.9%
$230.26Last close
$229.8220 day average−0.2%
$229.16Swing low (Sep 29)−0.5%
$228.7450 day average−0.7%
$225.94Pivot S1−1.9%
$221.86200 day average−3.6%
$156.9552 week low−31.8%
Indicators
RSI (14)
51.56
Middle of its range
Neutral
MACD
3.17
Below its signal line
Bearish
Stochastic
51.9
Middle of its range
Neutral
ADX (14)
32.9
Trending up
Williams %R
-56.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-19.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−6.3%
Change over 10 sessions
Bearish
ATR (14)
$14.96
Typical daily range, 6.5% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for JAZZ
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how JAZZ did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow JAZZ usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for JAZZHow many large options trades hit JAZZ, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in JAZZ in the last 90 days.
From SEC Form 4 filings by JAZZ's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether JAZZ is in one of them and how their past JAZZ trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company based in Dublin, Ireland. It develops and sells medicines for rare diseases, many of which have few or no existing treatment options. Its products include treatments for narcolepsy and other sleep disorders, medicines for certain forms of epilepsy, and cancer therapies. Its medicines are used by patients and prescribed by physicians in countries around the world.